Company Healthlead

HL

THA598010009

Drug Retailers

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Healthlead

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Drug Retailers

End-of-day quote Thailand S.E. Other stock markets 18:00:00 2024-05-19 EDT			5-day change	1st Jan Change
11.3 ^THB	-0.88%		-5.04%	+8.65%

02-29	Healthlead Public Company Limited Announces Management Changes	CI
02-29	Healthlead Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Healthlead Public Company Limited is a Thailand-based holding company. The principal businesses of the Company and its subsidiaries include pharmacy business distributing medicines, medical supplies, cosmeceuticals, supplements, medical devices, and other healthcare products as well as in business regarding invention business, developing, importing, and distributing healthcare products. It operates pharmacies under four brands namely Icare, Pharmax, vitaminclub, and Super Drug. The Company sells more than 10,000 stock-keeping units (SKUs) of medical supplies, cosmeceuticals, dietary supplements, medical equipment, and healthcare products via these pharmacies in response to customersâ various needs. Its pharmacies feature medicines, dietary supplements, medical equipment, household utensils, external healthcare products, and consumer goods. Its PRIME brand is a dietary supplement product, which includes PRIME Hibiki Collagen Pure and PRIME Acerola Cherry Extract 1200 MG.

THB in Million	2022	Weight	2023	Weight	Delta
Health Products for External Use and Dietary Supplements 100.0 %	1,520	100.0 %	1,636	100.0 %	+7.64%

THB in Million	2022	Weight	2023	Weight	Delta
Thailand 100.0 %	1,520	100.0 %	1,636	100.0 %	+7.64%

Managers	Title	Age	Since
Thachapol Chonwattanasakul CEO	Chief Executive Officer	46	18-11-30
Araya Tantanasin DFI	Director of Finance/CFO	54	18-12-31
Mattaya Panthukanon PSD	President	66	18-11-30
Supakorn Panthukanon COO	Chief Operating Officer	36	18-11-30
Sasithon Marukasonthi AUD	Comptroller/Controller/Auditor	-	22-08-31
Patharawan Siripongwilai SAM	Sales & Marketing	46	19-09-30
Thanapat Thongsukmak PRN	Corporate Officer/Principal	36	19-09-30
Budsakorn Ampankhao HRO	Human Resources Officer	53	18-12-31
Tatim Prakitnontakarn PRN	Corporate Officer/Principal	53	19-09-30

Members of the board	Title	Age	Since
Apirudee Hemajutha CHM	Chairman	68	18-11-30
Marayad Teeratomorn BRD	Director/Board Member	55	20-03-31
Thanasak Kulrattanarak BRD	Director/Board Member	50	20-03-31
Mattaya Panthukanon PSD	President	66	18-11-30
Thachapol Chonwattanasakul CEO	Chief Executive Officer	46	18-11-30
Supakorn Panthukanon COO	Chief Operating Officer	36	18-11-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	272,000,000	53,312,400 ( 19.60 %)	0	19.60 %

Name	Equities	%	Valuation
Supakorn Panthukanon 24.27 %	66,008,800	24.27 %	21 M ฿
Mattaya Panthukanon 20.73 %	56,375,000	20.73 %	18 M ฿
Sumeth Manosut 11.76 %	32,000,000	11.76 %	10 M ฿
Araya Tantanasin 8.252 %	22,446,200	8.252 %	7 M ฿
Thachapol Chonwattanasakul 4.338 %	11,800,000	4.338 %	4 M ฿
Thanakorn Phanthukanon 2.260 %	6,147,000	2.260 %	2 M ฿
Naris Jirawongprapha 1.765 %	4,800,000	1.765 %	2 M ฿
Pongsak Thamthatchaaree 1.474 %	4,009,400	1.474 %	1 M ฿
Sutee Lakanasutin 1.310 %	3,563,000	1.310 %	1 M ฿
Som Phop Tingthanathikun 1.287 %	3,500,000	1.287 %	1 M ฿

Healthlead PCL

99/4, Moo 10 Bang Muang

11140, Bang-Yai

http://www.healthleadgroup.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

11.3 THB

Average target price

12 THB

Spread / Average Target

+6.19%

Consensus

Estimates Revisions

Company calendar

Consumer Non-Cyclicals

Food & Drug Retailing

Food & Drug Retailing

Drug Retailers

Other Drug Retailers

	1st Jan change	Capi.
HEALTHLEAD	+8.65%	85.09M
WALGREENS BOOTS ALLIANCE, INC.	-31.75%	15.37B
JD HEALTH INTERNATIONAL INC.	-27.24%	12.7B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-26.65%	6.89B
MATSUKIYOCOCOKARA & CO.	-6.57%	6.26B
YIFENG PHARMACY CHAIN CO., LTD.	+10.76%	6.2B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+75.54%	4.96B
NAHDI MEDICAL COMPANY	-2.63%	4.63B
CLICKS GROUP LIMITED	-6.60%	3.98B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-9.24%	3.56B

Other Drug Retailers